chlorpromazine has been researched along with warfarin in 56 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 21 (37.50) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 17 (30.36) | 29.6817 |
2010's | 18 (32.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrews, PR; Craik, DJ; Martin, JL | 1 |
Duffy, EM; Jorgensen, WL | 1 |
Topliss, JG; Yoshida, F | 1 |
Faller, B; Wohnsland, F | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Caron, G; Ermondi, G | 1 |
Briand, X; Faller, B; Lázaro, E; Lowe, PJ | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Conradi, R; Lee, PH; Shanmugasundaram, V | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Gozalbes, R; Pineda-Lucena, A | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Boriss, H; Braggio, S; Corbioli, S; Fontana, S; Helmdach, L; Longhi, R; Schiller, J; Vinco, F | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Chang, G; Di, L; Huang, Y; Lin, Z; Liston, TE; Scott, DO; Troutman, MD; Umland, JP | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Chreifi, G; Do, HT; Li, H; Poulos, TL; Silverman, RB; Wang, HY | 1 |
Romankiewicz, JA | 1 |
Phillips, WA; Ratchford, JM; Schultz, JR | 1 |
Hanano, M; Iga, T; Sawada, Y; Sugiyama, Y | 1 |
Franz, JW; Jähnchen, E; Krieglstein, J | 1 |
Hahn, I; Krieglstein, G; Krieglstein, J; Tschentscher, K | 1 |
Barg, TsM | 1 |
Bollinger, A | 1 |
Keresztes-Nagy, S; Mais, RF; Oester, YT; Zaroslinski, JF | 1 |
Noble, IM | 1 |
Lal, S; Sourkes, TL | 1 |
Bickel, MH; Steele, JW | 1 |
Durno, D; Howie, JG; Petrie, JC | 1 |
Feuer, G; Lumb, G; Moddel, G; Sosa-Lucero, JC | 1 |
Földi, M; Zoltán, OT | 1 |
Blount, AW; Miller, DS | 1 |
Lee, RM; Livett, BH | 1 |
Luczynska, C; Wilson, K | 1 |
Kaidbey, K; Maguire, HC | 1 |
Kaidbey, KH; Kligman, AM | 1 |
Barrault, C; Bernard, FX; De Wever, B; Deguercy, A; Rosdy, M | 1 |
TUBARO, E | 1 |
Atarashi, K; Kobayashi, M; Kurita, M; Mori, K; Shimauchi, T; Tokura, Y | 1 |
Jung, M; Mathias, U | 1 |
de Ruiter, A; Hritz, J; Oostenbrink, C | 1 |
Alexandru, T; Amaral, L; Boni, M; Dinache, A; Nastasa, V; Pascu, A; Pascu, ML; Radu, E; Staicu, A; Stoicu, A | 1 |
Bi, C; Clarke, W; Hage, DS; Isingizwe, Z; Matsuda, R; Zhang, C | 1 |
5 review(s) available for chlorpromazine and warfarin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Prediction of the disposition of nine weakly acidic and six weakly basic drugs in humans from pharmacokinetic parameters in rats.
Topics: Animals; Antipyrine; Barbiturates; Biological Availability; Chlorpromazine; Diazepam; Drug Evaluation; Female; Half-Life; Humans; Kinetics; Male; Metabolic Clearance Rate; Pentazocine; Pharmaceutical Preparations; Phenylbutazone; Phenytoin; Propranolol; Quinidine; Rats; Species Specificity; Tissue Distribution; Tolbutamide; Valproic Acid; Warfarin | 1985 |
[Eye complications during use of various medicinal substances with general effects (review of the literature)].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Allopurinol; Anti-Bacterial Agents; Antimalarials; Cardiac Glycosides; Cataract; Child; Chloroquine; Chlorpromazine; Epinephrine; Ethambutol; Ethchlorvynol; Eye Diseases; Female; Humans; Miotics; Nalidixic Acid; Phosphates; Pilocarpine; Quinolines; Retinal Degeneration; Warfarin | 1969 |
The clinical significance of the effects of cigarette smoking on drug disposition.
Topics: Acetaminophen; Antipyrine; Benzodiazepines; Chlorpromazine; Clomipramine; Codeine; Humans; Pharmaceutical Preparations; Phenacetin; Propranolol; Smoking; Theophylline; Warfarin | 1983 |
[DRUGS ON DISPLAY].
Topics: Antihypertensive Agents; Antineoplastic Agents; Chlorpromazine; Chlorprothixene; Coumarins; Peptic Ulcer; Triflupromazine | 1963 |
51 other study(ies) available for chlorpromazine and warfarin
Article | Year |
---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Prediction of drug solubility from Monte Carlo simulations.
Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes.
Topics: Alkanes; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Membranes, Artificial; Octanols; Permeability; Pharmaceutical Preparations; Solubility; Water | 2001 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
New approach to measure protein binding based on a parallel artificial membrane assay and human serum albumin.
Topics: Humans; Kinetics; Membranes, Artificial; Permeability; Protein Binding; Serum Albumin | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software | 2009 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Development of an in silico model for human skin permeation based on a Franz cell skin permeability assay.
Topics: 1-Methyl-3-isobutylxanthine; Cell Line; Cell Membrane Permeability; Humans; Models, Biological; Quantitative Structure-Activity Relationship; Skin Absorption | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method.
Topics: Absorption; Albumins; Animals; Brain; Brain Chemistry; Cell Membrane; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; In Vitro Techniques; Lipids; Male; Microdialysis; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swine; Tissue Distribution | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Species independence in brain tissue binding using brain homogenates.
Topics: Animals; Brain; Dogs; Guinea Pigs; Humans; Macaca fascicularis; Mice; Rats; Species Specificity | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Improvement of Cell Permeability of Human Neuronal Nitric Oxide Synthase Inhibitors Using Potent and Selective 2-Aminopyridine-Based Scaffolds with a Fluorobenzene Linker.
Topics: Aminopyridines; Animals; Blood-Brain Barrier; Caco-2 Cells; Cell Membrane Permeability; Crystallography, X-Ray; Fluorobenzenes; Humans; Mice; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Rats; Structure-Activity Relationship; Swine; Theophylline; Verapamil | 2017 |
Effects of antacids on gastrointestinal absorption of drugs.
Topics: Animals; Antacids; Aspirin; Chlordiazepoxide; Chlorpromazine; Dicumarol; Digitoxin; Digoxin; Ephedrine; Guinea Pigs; Humans; Intestinal Absorption; Iron; Isoniazid; Levodopa; Naproxen; Pentobarbital; Pharmaceutical Preparations; Quinidine; Quinine; Rats; Sulfadiazine; Tetracyclines; Warfarin | 1976 |
Effects of colestipol hydrochloride on drug absorption in the rat II.
Topics: Animals; Cellulose; Chlorpromazine; Cholestyramine Resin; Clofibrate; Colestipol; Digitoxin; Digoxin; Hydrochlorothiazide; Intestinal Absorption; Male; Nicotinic Acids; Pharmaceutical Preparations; Phenobarbital; Polyamines; Rats; Tetracycline; Warfarin | 1976 |
[Influence of various drugs on the binding affinity of an albumin solution for promazine and chlorpromazine].
Topics: Alkaloids; Analgesics; Anti-Infective Agents; Antidepressive Agents; Barbiturates; Chemical Phenomena; Chemistry; Chlorpromazine; Chromatography, Gel; Coumarins; Cyclohexanes; Dibenzazepines; Methamphetamine; Methotrexate; Procaine; Promazine; Protein Binding; Pyridines; Quinolines; Serum Albumin, Bovine; Succinylcholine; Sympathomimetics | 1969 |
Distribution of chlorpromazine in a simplified blood influenced by various drugs.
Topics: Acetazolamide; Animals; Antidepressive Agents; Benzoates; Binding Sites; Binding, Competitive; Cattle; Chlorothiazide; Chlorpromazine; Coumarins; Deoxycholic Acid; Erythrocytes; Fatty Acids; Indomethacin; Phenylbutazone; Phenytoin; Probenecid; Protein Binding; Quinine; Salicylates; Serum Albumin, Bovine; Solubility; Sulfonamides; Suramin; Tetracycline; Thiopental | 1973 |
[Internal therapy of peripheral arterial blood circulation disorders].
Topics: Adenosine Triphosphate; Aged; Angiotensin II; Anti-Bacterial Agents; Blood Pressure; Chlorpromazine; Chronic Disease; Collateral Circulation; Coumarins; Epinephrine; Ergot Alkaloids; Exercise Therapy; Femoral Artery; Fibrinolytic Agents; Humans; Infusions, Parenteral; Male; Methoxamine; Nicotinic Acids; Papaverine; Popliteal Artery; Propranolol; Reserpine; Sympatholytics; Sympathomimetics; Thrombosis; Vascular Diseases | 1970 |
Interpretation of protein-drug interaction through fraction bound and relative contribution of secondary sites.
Topics: Binding Sites; Carbon Radioisotopes; Chlorpromazine; Chromatography, Gel; Computers; Humans; In Vitro Techniques; Kinetics; Ligands; Mathematics; Models, Biological; Pharmaceutical Preparations; Protein Binding; Quinidine; Salicylates; Serum Albumin; Spectrophotometry; Warfarin | 1974 |
Prescribing in pregnancy.
Topics: Carbimazole; Chlorpromazine; Diabetes Mellitus; Diazepam; Drug Prescriptions; Epilepsy; Female; Fetus; Heparin; Humans; Hyperthyroidism; Infant, Newborn; Insulin; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Smoking; Streptomycin; Tetracycline; Warfarin | 1974 |
Potentiation and inhibition of the amphetamine stereotypy in rats by neuroleptics and other agents.
Topics: Animals; Behavior, Animal; Chlorpromazine; Chlorprothixene; Compulsive Behavior; Dexamethasone; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Antagonism; Drug Interactions; Drug Synergism; Haloperidol; Humans; Lithium; Male; Mesoridazine; Methotrimeprazine; Motor Activity; Prochlorperazine; Promazine; Promethazine; Quinine; Rats; Tranquilizing Agents; Triflupromazine; Warfarin | 1972 |
Binding of basic and acidic drugs to rat tissue subcellular fractions.
Topics: Animals; Binding Sites; Brain; Cell Nucleus; Chlorpromazine; Imipramine; Kidney; Kinetics; Liver; Lung; Male; Methadone; Microsomes; Mitochondria; Muscles; Organ Specificity; Phenylbutazone; Protein Binding; Rats; Receptors, Drug; Salicylates; Sulfadimethoxine; Warfarin | 1974 |
Awareness and experience of general practitioners of selected drug interactions.
Topics: Amitriptyline; Antidepressive Agents; Chlorpromazine; Cognition; Dibenzazepines; Drug Interactions; Family Practice; Humans; Hypnotics and Sedatives; Imipramine; Insulin; Monoamine Oxidase Inhibitors; Physicians; Public Opinion; Scotland; Sulfonamides; Surveys and Questionnaires; Tolbutamide; Warfarin | 1974 |
Failure of various drugs to induce drug-metabolizing enzymes in extrahepatic tissues of the rat.
Topics: Adrenal Glands; Aminopyrine; Aniline Compounds; Animals; Brain; Chlorpromazine; Coumarins; Enzyme Induction; Female; Hexobarbital; Hydrochlorothiazide; Intestines; Kidney; Liver; Male; Methylcholanthrene; Metyrapone; Mixed Function Oxygenases; Organ Size; Oxidoreductases; Phenobarbital; Rats; Rats, Inbred Strains; Sex Factors | 1971 |
[Effect of chlorpromazine on conditioned reflexes and antagonistic activity of coumarin from Melilotus officinalis].
Topics: Animals; Chlorpromazine; Conditioning, Classical; Coumarins; Pantothenic Acid; Plant Extracts; Plants, Medicinal; Pyridoxine; Rats | 1970 |
Quinidine-induced recurrent ventricular fibrillation: (quinidine syncope) treated with transvenous pacemaker.
Topics: Adult; Atrial Fibrillation; Atropine; Blood Cell Count; Chlorpromazine; Coumarins; Creatine Kinase; Digitalis Glycosides; Diuretics; Electric Countershock; Electrocardiography; Female; Heart Valve Prosthesis; Humans; L-Lactate Dehydrogenase; Lactates; Lidocaine; Mitral Valve Stenosis; Pacemaker, Artificial; Paranoid Disorders; Pneumonia; Potassium Chloride; Quinidine; Rheumatic Heart Disease; Syncope; Ventricular Fibrillation | 1971 |
The esterases of guinea pig liver hydrolysing local anaesthetic esters.
Topics: Acetylcholine; Anesthetics, Local; Animals; Anthelmintics; Benzoates; Chlorpromazine; Choline; Cold Temperature; Coumarins; Esterases; Female; Guinea Pigs; Liver; Male; Phosphoric Acids; Physostigmine; Procaine; Quinolines | 1968 |
Experimental photoallergic contact dermatitis: a mouse model.
Topics: Animals; Chlorpromazine; Coumarins; Dermatitis, Contact; Disease Models, Animal; Lymph Nodes; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Inbred DBA; Photosensitivity Disorders; Salicylanilides; T-Lymphocytes; Ultraviolet Rays | 1982 |
Photomaximization test for identifying photoallergic contact sensitizers.
Topics: Adult; Allergens; Chlorpromazine; Coumarins; Humans; Phenols; Photosensitivity Disorders; Salicylanilides; Skin; Skin Tests | 1980 |
Development of a highly sensitive in vitro phototoxicity assay using the SkinEthic reconstructed human epidermis.
Topics: 4-Aminobenzoic Acid; 5-Methoxypsoralen; Adult; Antipruritics; Benzophenones; Chlorpromazine; Coloring Agents; Coumarins; Cytological Techniques; Dermatitis, Phototoxic; Dermotoxins; Dopamine Antagonists; Epidermal Cells; Epidermis; Fluorescent Dyes; Histidine; Humans; In Vitro Techniques; Methoxsalen; Neutral Red; Penicillin G; Penicillins; Promethazine; Rose Bengal; Sodium Dodecyl Sulfate; Sunscreening Agents; Surface-Active Agents; Tetracyclines; Ultraviolet Rays | 2000 |
Induction of keratinocyte apoptosis by photosensitizing chemicals plus UVA.
Topics: Anesthetics, Local; Anti-Infective Agents, Local; Antipsychotic Agents; Antitubercular Agents; Apoptosis; Bithionol; Cell Line, Transformed; Chlorpromazine; Coumarins; Diphenhydramine; Enoxacin; Enzyme Inhibitors; Fluoroquinolones; Humans; Keratinocytes; Necrosis; Photosensitizing Agents; Salicylanilides; Ultraviolet Rays | 2007 |
Determination of drug-serum protein interactions via fluorescence polarization measurements.
Topics: Blood Proteins; Chemistry Techniques, Analytical; Chemistry, Pharmaceutical; Chlorpromazine; Dipyridamole; Fluorescence Polarization; Fluorescent Dyes; gamma-Aminobutyric Acid; Humans; Naproxen; Orosomucoid; Phenylbutazone; Salicylic Acid; Serum Albumin; Warfarin | 2007 |
Impact of plasticity and flexibility on docking results for cytochrome P450 2D6: a combined approach of molecular dynamics and ligand docking.
Topics: 3,4-Methylenedioxyamphetamine; Catalytic Domain; Chlorpromazine; Computer Simulation; Coumarins; Cytochrome P-450 CYP2D6; Ligands; Models, Chemical; Molecular Structure; Propranolol; Stereoisomerism; Tamoxifen | 2008 |
Characterization of mixtures of compounds produced in chlorpromazine aqueous solutions by ultraviolet laser irradiation: their applications in antimicrobial assays.
Topics: Anti-Infective Agents; Biological Assay; Chlorpromazine; Chromatography, Liquid; Coumarins; Dimethyl Sulfoxide; Ethanol; Indoles; Isoindoles; Lasers; Mass Spectrometry; Microbial Sensitivity Tests; Oxygen; Singlet Oxygen; Spectroscopy, Fourier Transform Infrared; Staphylococcus aureus; Ultraviolet Rays; Zinc | 2015 |
Studies of drug interactions with alpha
Topics: Antibodies; Chlorpromazine; Chromatography, Affinity; Disopyramide; Drug Interactions; Humans; Imipramine; Orosomucoid; Pharmaceutical Preparations; Propranolol; Protein Binding; Warfarin | 2017 |